125 related articles for article (PubMed ID: 446076)
1. Urinary hydroxyproline in healthy patients and in prostate patients with and without bone metastases.
Heller W; Harzmann R; Bichler KH; Schmidt K
Curr Probl Clin Biochem; 1979; (9):249-56. PubMed ID: 446076
[TBL] [Abstract][Full Text] [Related]
2. Urinary hydroxyproline excretion as a marker of bone metastasis in prostatic cancer.
Rinsho K; Aoyagi K
Tohoku J Exp Med; 1982 Aug; 137(4):461-2. PubMed ID: 7123546
[TBL] [Abstract][Full Text] [Related]
3. Urine hydroxyproline excretion--a marker of bone metastases in prostatic carcinoma.
Bishop MC; Fellows GJ
Br J Urol; 1977; 49(7):711-6. PubMed ID: 597712
[TBL] [Abstract][Full Text] [Related]
4. [Use of urinary hydroxyproline excretion as a marker of bone metastases in prostatic cancer (1)].
Kurokawa K; Imai K; Yamanaka H; Tomaru Y; Kitaura K
Hinyokika Kiyo; 1985 Dec; 31(12):2119-25. PubMed ID: 2421558
[TBL] [Abstract][Full Text] [Related]
5. [Urinary and serum hydroxyproline in the diagnosis of bone metastases of prostatic cancer].
Gasser AB; Jeannet C; Depierre D; Courvoisier B
Schweiz Med Wochenschr; 1981 Feb; 111(8):246-51. PubMed ID: 7233140
[TBL] [Abstract][Full Text] [Related]
6. Effect of calcitonin and hexestrol on urinary excretion of hydroxyproline in a patient with prostatic cancer and bone metastases.
Matsushita Y; Hasegawa K; Sugimura R; Otomo S; Morii H
Endocrinol Jpn; 1974 Apr; 21(2):109-13. PubMed ID: 4408206
[No Abstract] [Full Text] [Related]
7. Urinary hydroxyproline excretion in patients with cancer.
Guzzo CE; Pachas WN; Pinals RS; Krant MJ
Cancer; 1969 Aug; 24(2):382-7. PubMed ID: 5796782
[No Abstract] [Full Text] [Related]
8. [The diagnostic value of radiological, nuclear medicine and biochemical methods for detection of bone metastases in carcinoma of the prostate (author's transl)].
Rost A; Fiedler U; Marshall F; Koppenhagen K
Radiologe; 1977 Jun; 17(6):249-55. PubMed ID: 887744
[TBL] [Abstract][Full Text] [Related]
9. Collagen cross-link metabolites in urine as markers of bone metastases in prostatic carcinoma.
Miyamoto KK; McSherry SA; Robins SP; Besterman JM; Mohler JL
J Urol; 1994 Apr; 151(4):909-13. PubMed ID: 7510346
[TBL] [Abstract][Full Text] [Related]
10. Use of urinary hydroxyproline excretion as a tumor marker in diagnosis and follow-up of prostatic carcinoma.
Unni Mooppan MM; Kim H; Wang JC; Tobin MS; Wax SH
Prostate; 1983; 4(4):397-405. PubMed ID: 6191318
[TBL] [Abstract][Full Text] [Related]
11. Bone alkaline phosphatase isoenzyme and urinary hydroxyproline in healthy subjects, patients with osteolytic metastases, and patients with primary hyperparathyroidism.
Stĕpán JJ; Mikulecký M; Bek V; Broulík P; Pacovský V
Neoplasma; 1989; 36(4):495-501. PubMed ID: 2770935
[TBL] [Abstract][Full Text] [Related]
12. [Hydroxyproline in the diagnosis of bone metastases in breast cancer].
Gasser AB; Depierre D; Alberto P; Courvoisier B
Schweiz Med Wochenschr; 1977 Jul; 107(28):984-6. PubMed ID: 897640
[TBL] [Abstract][Full Text] [Related]
13. Serial spot hydroxyproline/creatinine ratios in metastatic prostatic cancer.
Hopkins SC; Nissenkorn I; Palmieri GM; Ikard M; Moinuddin M; Soloway MS
J Urol; 1983 Feb; 129(2):319-23. PubMed ID: 6834497
[TBL] [Abstract][Full Text] [Related]
14. Relevance of hydroxyproline excretion to bone metastasis in breast cancer.
Gielen F; Dequeker J; Drochmans A; Wildiers J; Merlevede M
Br J Cancer; 1976 Sep; 34(3):279-85. PubMed ID: 974001
[TBL] [Abstract][Full Text] [Related]
15. Study of hydroxyproline excretion in patients with prostatic cancer.
Romics I; Budavári I; Kisbenedek L; Balogh F
Int Urol Nephrol; 1981; 13(3):275-8. PubMed ID: 7327902
[TBL] [Abstract][Full Text] [Related]
16. [Urinary hydroxyproline excretion as a marker of bone metastasis in prostatic cancer].
Rinsho K
Nihon Hinyokika Gakkai Zasshi; 1983 Jan; 74(1):76-80. PubMed ID: 6191064
[No Abstract] [Full Text] [Related]
17. [Current status of diagnosis and stage classification of prostatic carcinoma].
Harzmann R; Bichler KH
Med Klin; 1977 Oct; 72(40):1649-54. PubMed ID: 199828
[No Abstract] [Full Text] [Related]
18. Early morning hydroxyproline excretion in patients with breast cancer.
Powles TJ; Rosset G; Leese CL; Bondy PK
Cancer; 1976 Dec; 38(6):2564-6. PubMed ID: 1000483
[TBL] [Abstract][Full Text] [Related]
19. [Urinary hydroxyproline excretion as a marker of bone metastasis in prostatic cancer (II): Correlation between extent of metastatic lesions in whole body bone scintigraphy of patients with prostatic cancer and tumor markers in blood and urine].
Nemoto S; Rinsho K
Nihon Hinyokika Gakkai Zasshi; 1984 Jan; 75(1):53-8. PubMed ID: 6539837
[No Abstract] [Full Text] [Related]
20. Total and nondialyzable hydroxyproline excretion in Stage D2 prostate cancer.
Hopkins SC; Palmieri GM; Niell HB; Moinuddin M; Soloway MS
Cancer; 1984 Jan; 53(1):117-21. PubMed ID: 6689994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
